[Antioxidant agents in neuroprotection treatment of glaucoma].

@article{Egorov2013AntioxidantAI,
  title={[Antioxidant agents in neuroprotection treatment of glaucoma].},
  author={E. A. Egorov and A A Gvetadze and Nina G Davydova},
  journal={Vestnik oftalmologii},
  year={2013},
  volume={129 2},
  pages={69-70, 73}
}
Purpose was to study efficiency and safety of mexidol in combined therapy in patients with primary open-angle glaucoma (POAG). 94 patients (185 eyes) at the age of 18-75 years old with POAG I-III stages were divided into 3 groups: 50 patients received combined therapy of mexidol 100 mg and picamilon 150 mg, 22 patients received combined therapy of mexidol 300 mg and picamilon 150 mg, 22 patients received only picamilon 150 mg. All medicine was administered qd during 14 or 21 days. Examination… CONTINUE READING